Ashton Thomas Private Wealth’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Ashton Thomas Private Wealth's DGX Position: Q3 2026 in Review
Ashton Thomas Private Wealth increased its Quest Diagnostics (DGX) stake by 2.3% in Q3 2026, buying an estimated $49K and bringing the position to 9,565 shares worth $2.23M. The position accounts for 0.04% of the portfolio, ranked #373.
Ashton Thomas Private Wealth first reported a position in DGX in Q1 2020 and has held it in 10 quarters since. 1,126 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Ashton Thomas Private Wealth held 9,565 shares of Quest Diagnostics worth $2.23M as of Q3 2026.
- Ashton Thomas Private Wealth bought 212 Quest Diagnostics shares in Q3 2026, an estimated $49K.
- Quest Diagnostics made up 0.04% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #373 holding.
- Ashton Thomas Private Wealth first reported a position in Quest Diagnostics in Q1 2020 and has held it in 10 quarters since.
- 1,126 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.